Background: Antenatal use of steroids is a common practice in pregnancy for the treatment of various autoimmune diseases. The prolonged administration of exogenous glucocorticoids to pregnant women exerts a direct effect on the suprarenal gland structure and functions of neonates and infants.
Objective: This study aimed to assess the impact of prenatal dexamethasone and hydrocortisone on fetal suprarenal cortical structure and StAR protein expression in early and late pregnancy at 1 and 15 days postnatal age.
Methods: 40 pregnant rats were included in this study, allocated into two experimental groups in early or late pregnancy, as dexamethasone (1 mg/kg/once/day) or hydrocortisone (9 mg/kg/day/every 8 h) IP injection in early or late pregnancy. The control group of 20 pregnant rats received (1 ml N.S). At 1 and 15 days of age, Neonatal suprarenal glands were assessed for histological architecture by H&E, StAR immunohistochemistry, and TUNEL assay.
Results: Both dexamethasone and hydrocortisone induced marked histological changes, including necrosis, apoptosis, and fibrosis, especially in dexamethasone-treated neonates, with statistically significant reduction in StAR protein expression in 1 and 15-day-old neonates.
Conclusion: Antenatal dexamethasone treatment in late pregnancy affects suprarenal gland development and function with cell loss through apoptosis and necrosis, which eventually reduces the steroidogenesis function of the suprarenal cortex.
If you have any questions about submitting your review, please email us at [email protected].